Home › Wedbush Weighs in on Ironwood Pharmaceuticals' FY2018 Earnings
 

Keywords :   


Wedbush Weighs in on Ironwood Pharmaceuticals' FY2018 Earnings

2015-11-08 08:39:41| Biotech - Topix.net

Analysts at Wedbush issued their FY2018 EPS estimates for shares of Ironwood Pharmaceuticals in a report released on Tuesday, Zacks Investment Research reports. Wedbush analyst D. Nierengarten expects that the firm will earn $1.01 per share for the year.

Tags: earnings pharmaceuticals weighs ironwood

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »